CHICAGO, April 23 (Reuters) - Aaron Smith, a fifth-generation pea and lentil farmer in northern Idaho, says the dizzying rise of GLP-1 medications and a social media-fueled protein craze may be his ...

Welcome to Regeneron's conference call to discuss its C5 Complement Development Program. My name is Shannon, and I will be your operator for today's call. [Operator Instructions] Please note that this ...

Good Monday morning in New York City, where it's been said this lawyer who represents alleged mobsters is good at his job. Gothamist is funded by sponsors and member donations Gothamist is funded by ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Want to stay on top of ...

Five highly anticipated bars and restaurants are set to open soon in the Columbus area. Wolf's Ridge at The Worthington Inn is expected to open in late April, reviving a historic location. The Bier ...

A new study finds quitting GLP-1 drugs like Ozempic can reverse health gains and increase heart health risks. Patients who stopped taking the medication saw a higher risk for heart attack, stroke, or ...

A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. GLP-1s are ...

The benefits of GLP-1 receptor agonists may extend beyond weight management, with results of a large study pointing to their potential role in preventing and treating a wide range of substance use ...

The NFL offseason continues to trudge along as free agency has made it through its first week, and the Green Bay Packers have been able to add to their roster, as they typically have done under Brian ...

Dieticians are warning that GLP-1 use can lead to extreme malnutrition, manifesting in diseases like scurvy, amid findings that the vast majority of studies fail to consider patients’ eating habits.

Telehealth company Hims & Hers on Monday announced a “strategic shift” in its business model, partnering with pharmaceutical company Novo Nordisk to sell its blockbuster GLP-1 medication and stop ...

GLP-1 medications are being discussed everywhere right now: In medical offices. On social media. In celebrity interviews. But what I’m paying attention to in my therapy office is not just the ...